Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent (REMEDEE)

This study has been completed.
Information provided by (Responsible Party):
OrbusNeich Identifier:
First received: August 26, 2009
Last updated: March 28, 2016
Last verified: March 2016